Skip to content

ERCP BRush cytology of pancreatobiliary strictures – Infinity versus Boston Scientific RX cytology brush: a randomized controlled trial

ERCP BRush cytology of pancreatobiliary strictures – Infinity versus Boston Scientific RX cytology brush: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25595
Enrollment
106
Registered
2015-09-02
Start date
2015-10-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatobiliary stricture suspicious for malignancy Pancreatobiliaire stricturen verdacht voor maligniteit

Interventions

During ERCP biliary brushing will be performed with either standard RX cytology brush (group 1) or the Infinity cytology device (group 2).

Sponsors

Academic Medical Center Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ‐ Patients with pancreatobiliary stricture suspicious for malignancy • Who are planned to undergo ERCP with biliary brush cytology OR • Who are planned to undergo ERCP with biliary stent placement for (suspected) malignant strictures ‐ ≥18 years old ‐ Written informed consent

Exclusion criteria

Exclusion criteria: ‐ Inability to cannulate the papilla ‐ Hilar biliary obstruction, defined as stenosis located within 2 cm of the hilum ‐ Not fulfilling standard criteria to undergo ERCP with biliary brush according to local guidelines

Design outcomes

Primary

MeasureTime frame
The main study endpoint is the difference in sensitivity of brush cytology between the standard RX cytology brush and the Infinity cytology device.

Secondary

MeasureTime frame
- Diagnostic performance - Cellular yield - Complication rate, such as bleeding, cholangitis or pancreatitis

Contacts

Public ContactS. Lekkerkerker

Dept. of Gastroenterology and Hepatology Academic Medical Center Meibergdreef 9, C2-310

s.j.lekkerkerker@amc.nl+31-205662061

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)